<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01323686</url>
  </required_header>
  <id_info>
    <org_study_id>sksCRT</org_study_id>
    <nct_id>NCT01323686</nct_id>
  </id_info>
  <brief_title>Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy</brief_title>
  <acronym>ImagingCRT</acronym>
  <official_title>Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate if imaging guided optimal left ventricular (LV) lead
      placement improves the response rate to cardiac resynchronization therapy (CRT). Consecutive
      patients meeting the standard criteria for CRT are included in a prospective, double-blinded,
      randomized trial to LV lead positioning either 1) guided by cardiac imaging using
      echocardiography, single-photon emission computed tomography, and visualization of cardiac
      venous anatomy (cardiac computed tomography (CT), venography) to target an epicardial vein at
      the site of latest mechanical activation without scar tissue or 2) using standard LV lead
      placement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with clinical response to CRT</measure>
    <time_frame>6 months after CRT implantation</time_frame>
    <description>Response to CRT defined as a combination of survival, free of hospitalization for heart failure, and improved functional status. The primary endpoint is attained if the patient is registered for one of the following three events:
Death from any cause.
Hospitalization for heart failure.
No improvement in New York Heart Association (NYHA) functional class and &lt;10% improvement in 6-minutes hall walk at end of study period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization for heart failure</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in NYHA functional class</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in 6-Minutes Hall Walk</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality of Life</measure>
    <time_frame>6 months after CRT implantation</time_frame>
    <description>Using Minnesota Living with Heart Failure questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Biochemical marker of heart failure</measure>
    <time_frame>6 months after CRT implantation</time_frame>
    <description>Nt-ProBNP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in LV Ejection Fraction</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of LV end-diastolic volume</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of LV end-systolic volume</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of LV dyssynchrony</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of mitral regurgitation grade</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of CRT implantation</measure>
    <time_frame>During CRT implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6 months after CRT implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Imaging guided LV lead placement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Empiric LV lead placement</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>LV lead placement using standard clinical routine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Imaging guided optimal LV lead placement</intervention_name>
    <description>LV lead placement guided by cardiac imaging using echocardiography, single-photon emission computed tomography, and CT to target a cardiac vein at the site of latest mechanical activation without scar tissue.
Visualization of cardiac venous anatomy is performed using cardiac CT if not contraindicated by depressed renal function (estimated glomerular filtration rate &lt;30 ml/min) or allergy to contrast media. In that case, a coronary venogram is used.</description>
    <arm_group_label>Imaging guided LV lead placement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic heart failure (New York Heart Association functional class II - IV)
             despite stabile optimal medical therapy.

          -  ECG with QRS ≥ 120 milliseconds and left bundle branch block (LBBB) or paced QRS ≥ 180
             milliseconds.

          -  LV systolic dysfunction (Ejection Fraction ≤ 35%).

          -  written informed consent.

        Exclusion Criteria:

          -  Expected lifetime &lt; 6 months.

          -  Recent myocardial infarction (&lt; 3 months).

          -  Pregnant or lactating.

          -  Inadequate echocardiographic images for determination of site with latest mechanical
             activation

          -  No written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens C. Nielsen, Professor, PhD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders Sommer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiology, Aarhus University Hospital, Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>DK-8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2011</study_first_submitted>
  <study_first_submitted_qc>March 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2011</study_first_posted>
  <last_update_submitted>September 4, 2014</last_update_submitted>
  <last_update_submitted_qc>September 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

